Helix BioPharma Market Cap

Helix BioPharma has a market cap or net worth of $35.30 million as of June 6, 2025. Its market cap has decreased by -4.38% in one year.

Market Cap

35.30M

Enterprise Value

33.85M

Revenue

n/a

Ranking

n/a

PE Ratio

n/a

Stock Price

$0.60

Market Cap Chart

Since August 15, 1995, Helix BioPharma's market cap has increased from 6.90M to 35.30M, an increase of 411.82%. That is a compound annual growth rate of 5.63%.

Market Cap History

Date	Market Cap	% Change
May 28, 2025	35.30M	16.40%
Dec 31, 2024	30.32M	-11.99%
Dec 29, 2023	34.45M	8.43%
Dec 30, 2022	31.77M	-5.92%
Dec 31, 2021	33.77M	-36.31%
Dec 31, 2020	53.03M	-58.92%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Endo Inc.	1.63B
Veradigm	730.27M
Nika Pharmaceuticals	666.65M
Tian'an Technology Group	614.49M
Elite Pharmaceuticals	597.81M
CytoDyn	433.92M
Glass House Brands	430.39M
Northwest Biotherapeutics	384.07M

Market Cap Rankings